Home/MiMedx Group/Timothy R. Wright
TR

Timothy R. Wright

CEO, Regenerative Medicine & Biologics

MiMedx Group

MiMedx Group Pipeline

DrugIndicationPhase
EPIFIX® / AMNIOFIX®Diabetic Foot UlcersPost-Market Study
EPICORD®Surgical Recovery (e.g., Tendon Repair)Clinical Studies
AMNIOBURN®Partial-Thickness BurnsClinical Evaluation
CELERA™Surgical Recovery (Dural Repair)Clinical Studies
HELIOGEN®Ocular Surface DiseaseCommercial
AXIOFILL®Surgical Void FillingCommercial
MiMedx Patient RegistryMultiple Wound & Surgical IndicationsReal-World Evidence